RxDoctor Payments Data

Eduardo Garcia

Cardiovascular Disease · Dearborn, MINPI 1730149451

Payments from drug & device makers

$1,228in general payments, 2019–2025

Across 76 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$269
  • Sanofi-aventis U.S. LLC$127
  • AstraZeneca$116
  • Johnson & Johnson$98
  • Boehringer Ingelheim$89
  • Boston Scientific$70
  • plus $460 from 15 others

What the payments were for

  • Food & beverage$1,228100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,228 in reported general payments places this provider in the 35th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan

Other cardiovascular disease in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →